Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Chemomab Therapeutics Ltd. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 17 | 14 | −3 |
| Shares | 3.73M | 4.23M | +499.1K (+13.4%) |
| Value | $4.07M | $4.91M | +$839.8K (+20.6%) |
New holders (2)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 20,569 | $23.9K | 0.00% |
| JPMorgan Chase & Co | 1,180 | $1.37K | 0.00% |
Sold out (5)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Virtu Financial LLC | 30,803 | $34.0K |
| Two Sigma Securities, LLC | 22,104 | $24.1K |
| XTX Topco Ltd | 13,274 | $14.5K |
| Wetzel Investment Advisors, Inc. | 11,000 | $12.0K |
| Moser Wealth Advisors, LLC | 500 | $545 |